跳至主要内容
临床试验/ACTRN12622000661774
ACTRN12622000661774已完成未知

Bedside Neuromodulation of Persistent Pain and Allodynia with Caloric Vestibular Stimulation: An Effectiveness Trial

Alfred Health0 个研究点目标入组 38 人开始时间: 2022年5月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Alfred Health
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • (i) persistent pain (>3 months) at or below deafferentation level for phantom limb pain and spinal cord injury pain;
  • (ii) persistent pain (> 3months) in complex regional pain syndrome as diagnosed by treating pain clinician;
  • (iii) musculoskeletal persistent pain (> 3 months) for non-specific persistent pain patients.

排除标准

  • (i) epilepsy or any brain disorder;
  • (ii) ear disease within the past five years;
  • (iii) pregnancy;
  • (iv) cardiac or respiratory disease (unless cleared by treating specialist);
  • (v) alcohol or substance dependence, or psychiatric comorbidity (except depression).
  • Absence of these conditions was confirmed via medical records and clinical interview.

研究者

发起方
Alfred Health

相似试验